Business
Trading update & Expansion of supply agreement
Trading update & Expansion of supply agreement.
About this update from Ekf Diagnostics Holdings Plc
[{"type":"text","content":"\n \n \n \n RNS Number : 8829T\n EKF Diagnostics Holdings PLC\n 30 March 2021\n \n \n \n \n This announcement contains inside information\nfor the purposes of Article 7 of Regulation (EU) No 596/2014 as it forms part of UK law\nby virtue of the European Union (Withdrawal) Act 2018 (\"MAR\")\n \n \n \n \n \n EKF Diagnostics Holdings plc\n \n \n (\"EKF\", the \"Company\" or the \"Group\")\n \n \n \n \n \n Trading update & \n \n \n Significant expansion of supply agreement for COVID-19 sample collection kits\n \n \n Private sector partnership with EKF for global staff testing programme\n \n \n \n \n \n EKF Diagnostics Holdings plc (AIM: EKF), the AIM-listed point-of-care business, announces that it has signed a new multi-million dollar global supply contract with its partner from the private sector. The original agreement with this partner, \n \n announced on 5 August 2020\n \n , covered the supply of COVID-19 sample collection kits to be used as part of a staff testing programme for the UK only. The original contract commenced with an initial order worth £3m for the UK, and the Company has received additional orders approaching a further £3m to support the planned global expansion of the contract. \n \n \n \n \n \n Under this new multiyear global supply contract, EKF will now support its partner's world-wide staff testing initiative, with orders being fulfilled from EKF's production sites in the UK, Germany and the United States. The Company expects orders from the expanded agreement to reflect EKF's increased contribution to their partner's global testing programme, and therefore this agreement is expected to facilitate future orders which will contribute materially to 2021 performance and beyond. The contract has an initial term of two years after which it renews automatically on a monthly basis.\n \n \n \n \n \n EKF is supporting its partner's global staff testing initiative, which aims to offer free, regular COVID-19 testing to its frontline workforce across all of the many geographies in which it operates. The programme is designed to identify asymptomatic carriers who would not have been tested through national testing services, to detect the virus earlier before it spreads.\n \n \n \n \n \n Further to the \n \n announcement on 12 January 2021\n \n , trading in the first quarter ...